| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531502 | International Immunopharmacology | 2018 | 6 Pages |
Abstract
sTim-3 and sGal-9 were promising biomarkers for allograft dysfunction, but unable to differentiate allograft rejection from other causes of renal dysfunction in KTRs. Moreover, long-term administration of sirolimus would up-regulate sCEACAM-1 level, while exert similar regulatory effects on Tim-3 and Gal-9 compared to tacrolimus.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ya Mei Li, Yun Ying Shi, Yi Li, Lin Yan, Jiang Tao Tang, Yang Juan Bai, Xiao Juan Wu, Bo Dai, Yuan Gao Zou, Lan Lan Wang,